Patient Enrollment Begins in Third and Final Cohort of the P

Athersys, Inc. , a regenerative medicine company developing MultiStem® cell therapy for critical care indications, announces patient enrollment has begun in the third and final cohort in... | June 1, 2023

Related Keywords

Texas , United States , Houston , Texas Medical Center , Memorial Hermann Hospital , University Of Texas , Charless Cox Jr , Dan Camardo , Uthealth Neurosciences , D Bradley Mcwilliams School Of Biomedical Informatics , Harris Health Lyndonb Johnson Hospital , Mcgovern Medical School , Twitter , Technology Enterprise Consortium , Athersys Inc , Department Of Defense , Nasdaq , Kathrineg Mcgovern Medical School , Accountable Care Organization , University Of Texas System Board Regents , Memorial Hermann Health System , Memorial Hermann Foundation , Facebook , Department Of Pediatric Surgery , Ut Health Services , Level One Trauma Center , Robert Cizik School Of Nursing , Uthealth Harris County Psychiatric Center , Linkedin , Texas Health Science Center , Memorial Hermann Texas Medical Center , Medical Technology Enterprise Consortium , Memorial Hermann , Hermann Texas Medical Center , Chief Executive Officer , Cynthia Mitchell Distinguished Chair , Glassell Family Distinguished Chair , Pediatric Surgery , Principal Investigator , Texas System Board , Health University , Robert Cizik School , Govern Medical School , Mcwilliams School , Biomedical Informatics , Harris County Psychiatric Center , Harris Health Lyndon , Southeast Texas , Greater Houston , Memorial Hermann Surgical Hospital First Colony , Memorial Hermann Surgical Hospital Kingwood , Memorial Hermann Rehabilitation , Private Securities Litigation Reform Act , Athersys , Nc Stock Exchange , News , Information , Press Release , Regenerative , Medicine , Company , Developing , Fell , Therapy , Or , Critical , Mare , Nnounces , Patient , Enrollment , Gas , Egun , N , The , Third , End , Final , Ohort Athx Us04744l2051 ,